Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study
Human coronaviruses represent a significant disease burden; however, there is currently no antiviral strategy to combat infection. The outbreak of severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) less than 10 years later demonstrates the potential of coron...
Main Authors: | Michael Berry, Burtram C. Fielding, Junaid Gamieldien |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-12-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/7/12/2963 |
Similar Items
-
Chlorogenic acid may be a potent inhibitor of dimeric SARS-CoV-2 main protease 3CLpro: an in silico study
by: Rajkumar Sanjay Patil, et al.
Published: (2021-03-01) -
Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
by: Yuwei Wang, et al.
Published: (2020-11-01) -
TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
by: Mohammad Azam Ansari, et al.
Published: (2020-11-01) -
Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
by: Alessandro Grottesi, et al.
Published: (2020-07-01) -
Massively-Parallel Computational Identification of Novel Broad Spectrum Antivirals to Combat Coronavirus Infection
by: Berry, Michael
Published: (2021)